Carl Zeiss Meditec rises after more positive outlook

Carl Zeiss Meditec AG

12/12/2023 08:12

** Shares in Carl Zeiss Meditec  AFXG.DE  jump more than 6%
after the German medical technology group posted higher annual
revenue and gave a more optimistic outlook
    ** The company's FY 2022/23 revenue rises 9.8% to 2.09 bln
euros ($2.24 bln)
    ** It expects FY 2023/24 revenue growth to be at least as
high as market growth and EBIT to be roughly level with previous
year
    ** In the medium term, the company expects to stabilize EBIT
margin sustainably above 20%, while extensive investments will
also be continued
    ** A local trader says the 2023/24 outlook seems better than
the fears that emerged over the last weeks, and the medium-term
outlook is more optimistic than earlier this year
    ** "Should be enough for AFX shares to continue recent
uptrend," the trader says
    ** The stock is the top performer on Germany's mid-cap index
 .MDAXI 

($1 = 0.9279 euros)

 (Reporting by Ozan Ergenay)
 ((ozan.ergenay@thomsonreuters.com))